UNSPSC 51284001: Apicycline

This classification denotes a tetracycline antibiotic with the molecular formula C30H38N4O11, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier T1Y573BS7H, chemically known as alpha-(4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamido)-4-(2-hydroxyethyl)-1-piperazineacetic acid but generally known as apicycline, which bears US NIH Compound Identifier 5490216.

UNSPSC 51284001 Apicycline, a Commodity code, does not map to meaningful recent state and local procurement activity. The code nominally describes apicycline, a tetracycline-class antibiotic, yet the recent opportunities tagged under it include naloxone procurement for opioid-overdose response, generic pharmaceutical and OTC product distribution through cooperative purchasing, direct-to-manufacturer pharmacy initiatives, and emergency medical supply acquisition for fire rescue. None of these solicitations involves apicycline specifically, and the opportunities span pharmaceutical distribution infrastructure, emergency response consumables, and pharmacy benefit management rather than a single-product antibiotic purchase. The issuing bodies include state health agencies (Texas HHS Commission), county health departments (Seminole County, Florida), municipal fire departments (City of Tampa), and multi-state cooperative purchasing alliances (MMCAP), reflecting broad jurisdiction participation in pharmaceutical and medical-supply procurement.

Activity appears concentrated in Florida and Minnesota with secondary representation from Texas, though the code's mismatch to the actual commodities being bought signals either a data-classification error in the source records or abandonment of apicycline-specific procurement at the state and local level. Representative recent opportunities include Seminole County's IFB for naloxone and drug deactivation systems (IFB 60459723LAS, due July 26, 2023), the City of Tampa's sealed-bid procurement for medical and first aid supplies for fire rescue (Bid 26-P-00145, due March 13, 2026, estimated at $700,000.00 with SLBE set-aside), and MMCAP's RFP for generic multi-source pharmaceuticals and OTC products (S1070000015802, due March 26, 2026). The code shows no active market for apicycline itself and should not be relied upon to forecast state and local antibiotic procurement.